Q4 2018 Investor Presentation

> Proven Capital Management Capital Deployment Investment for Growth New Products Geographic expansion Acquisitions Free Cash Flow returned to Shareholders Last twelve months combined dividend and stock repurchase = 57% of free cash flow Increasing Dividend FY 2018 dividend payout ratio of 39% of Adj. net income Dividend per share increased by 6% over prior year Combined dividend and buy-back over rolling 5 years = 71% of free cash flow © 2018 ResMed | Q4 2018 Investor Presentation | 35 ResMed

View entire presentation